Search

everythinglearnresearchcommunity

for

Search:↓

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

A woman's hair turned white after taking a cancer drug called dasatinib.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

A new molecule was found to be a safe and effective skin lightener and anti-aging product.

PTH-CBD agonists may help regrow hair after chemotherapy.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

The drug combination was safe and showed promise in treating advanced tumors.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Early detection of chemotherapy side effects allows treatment adjustments, improving patient outcomes.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

DOPE:DOPC liposomes can improve targeted cancer drug delivery, reducing side effects and increasing effectiveness.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Advanced fluorescence technology effectively treats skin discoloration from certain creams.

M30 is a promising treatment for preventing hair loss during chemotherapy.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.